N-acylethanolamines (NAEs) are lipid-derived signaling compounds. For example, arachidonoyl ethanolamide is an endogenous cannabinoid (CB) that activates the CB1 and CB2 receptors. Palmitoleoyl Ethanolamide (POEA) is an NAE that is produced endogenously from palmitoleic acid. Unlike arachidonoyl ethanolamide and palmitoyl ethanolamide, POEA does not have antinociceptive effects, as assessed in the formalin-evoked pain model.
N-acylethanolamines (NAEs) are lipid-derived signaling compounds. For example, arachidonoyl ethanolamide is an endogenous cannabinoid (CB) that activates the CB1 and CB2 receptors. Palmitoleoyl Ethanolamide (POEA) is an NAE that is produced endogenously from palmitoleic acid. Unlike arachidonoyl ethanolamide and palmitoyl ethanolamide, POEA does not have antinociceptive effects, as assessed in the formalin-evoked pain model.[Cayman Chemical]
ChEBI: Palmitoleoyl ethanolamide is an N-acylethanolamine 16:1 that is the ethanolamide of palmitoleic acid. It has a role as an anti-inflammatory agent. It is an endocannabinoid and a N-acylethanolamine 16:1. It is functionally related to a palmitoleic acid.
